Skip to main content
. 2021 Aug 17;77(8):762–768. doi: 10.1136/thoraxjnl-2021-216865

Table 1.

PICOS question and inclusion/exclusion criteria

Inclusion Exclusion
Patient
  • Any patient aged ≥18 years

  • Diagnosed with NSCLC

  • Investigations and treatment performed in an elective secondary or tertiary care setting

  • NSCLC not examined in isolation from other cancer diagnoses

  • Non-standard or emergency care pathways included

  • Time intervals not measurable or not relevant to secondary/tertiary care

Intervention
  • Any with the intention of reducing part or all of time intervals from primary care referral to treatment

NA
Control
  • Usual care

NA
Outcome
  • Lung cancer-specific survival

  • DFS

  • OS

  • Disease progression (eg, upstaging, change in proposed treatment)

  • Outcomes not directly correlated to timeliness

Studies
  • Any interventional or observational study

  • Published January 2012–present

  • Not available in English language

  • Abstract only

  • No original data reported

DFS, disease-free survival; NSCLC, non-small cell lung cancer; OS, overall survival.